Jacqueline M. Tarrant

Statistics

Publications

Citations

2.3K

H-Index

Active since

2001

Affiliations

Walter and Eliza Hall Institute of Medical Research(Current)

Gilead Sciences (United States)

Cornell University

The Royal Melbourne Hospital

New York State College of Veterinary Medicine

Jacqueline M. Tarrant is an author at Walter and Eliza Hall Institute of Medical Research specializing in pharmacology, medicine, and cancer pharmacology.

Publications per year

2001–2020

Publications

Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy

Joel D. Leverson, Darren C. Phillips, Michael J. Mitten et al. · Science Translational Medicine · 2015 · 541 citations · Full text

Medicine, Oncology, Pharmacology +14

Effect of selective LRRK2 kinase inhibition on nonhuman primate lung

Reina N. Fuji, Michael Flagella, Miriam Baca et al. · Science Translational Medicine · 2015 · 370 citations

Pharmacy, Pharmacology, Toxicology +13

GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease

Rohit Loomba, Zeid Kayali, Mazen Noureddin et al. · Gastroenterology · 2018 · 334 citations · Full text

Medicine, Pathology, Hepatology +15

Addressing Safety Liabilities of TfR Bispecific Antibodies That Cross the Blood-Brain Barrier

Jessica A. Couch, Yang Yu, Yin Zhang et al. · Science Translational Medicine · 2013 · 266 citations

Pharmacy, Immunology, Pharmacology +17

Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis

Eric Lawitz, Angie Coste, Fred Poordad et al. · Clinical Gastroenterology and Hepatology · 2018 · 215 citations

Medicine, Pharmacology, Pharmacotherapy +14

1–5 of 24